Distributor of BergaMet products to North America.
With multiple trials supporting the effectiveness of BergaMet, leading cardiologists and doctors world wide are using and recommending BergaMet products. The only citrus bergamot company to be approved by the Accademia del Bergamotto in Italy.
Bergamot is positioned to become a first-line therapy for individuals with metabolic syndrome. In addition to its positive effects on cardiovascular risk factors, this extract also activates AMPK. AMPK is a central regulator of energy and is thus involved in glucose and fatty acid metabolism. “Turning on” AMPK improves insulin sensitivity, promotes glucose uptake in cells, and suppresses the synthesis of glucose in the liver, thus lowering blood sugar. It also stimulates the burning of free fatty acids and facilitates weight control.
BergaMet is the most powerful citrus bergamot supplement available with BPF of 47% or greater.
What is Bergamot?
Bergamot is an Italian ‘Superfruit’ from the Calabrian region with amazing anti-oxidant properties
The extracted juice from the bergamot fruit helps control blood sugar, and improves overall arterial function and cardiovascular health
Our Medical Team
BergaMet NA has a highly experienced medical team based in Italy, Australia and the USA
BergaMet N.A. is a North American company with the rights to distribute BergaMet products to the U.S., Canada and Mexico. The operation runs out of Las Vegas, Nevada. BergaMet is available worldwide and is the highest concentrate BPF available.
The BergaMet brand was founded by Nathealthsolutions in Australia and is the only company approved by the Accademia del Bergamotto of Italy. This is a prestigious honor awarded to the highest quality citrus bergamot products and Nathealthsolutions are privileged to have a number of associated awards.